Skip to main content
Turkish Journal of Urology logoLink to Turkish Journal of Urology
. 2022 Jul 1;48(4):294–298. doi: 10.5152/tud.2022.22012

Crossing Vessel in Pelvi Ureteric Junction Obstruction: A Histopathological Analysis

Sanjeet Kumar Singh 1,, Anjana Singh 2,, Krishna Kumar Yadav 3, Gurunam Girniwale 1, Nuzhat Husain 3, Alok Srivastava 1, Chandra Kant Munjewar 1
PMCID: PMC9612698  PMID: 35913445

Abstract

Objective:

The aim of the study is to identify whether crossing vessel is a cause or an associated finding in Pelvi Ureteric Junction Obstruction.

Material and methods:

This is a prospective study of a total of 128 patients who underwent laparoscopic pyeloplasty from January 2016 to June 2020. All patients who underwent laparoscopic pyeloplasty and pelvi ureteric junction segments were sent for histopathological examination. The presence of crossing vessels is documented intraoperative and patients were divided into two groups, group 1 having pelvi ureteric junction obstruction with crossing vessel, and group 2, pelvi ureteric junction obstruction without crossing vessels. Histopathological examination findings of pelvi ureteric junction segment including inflammation, fibrosis, muscle hypertrophy, muscle disarray, and synaptophysin were recorded. Unpaired Student t-test was used for comparing differences between continuous normally distributed data from 2 samples and non-parametric tests were applied for continuous data.

Results:

Of the total 128 patients, crossing vessels were identified in 42 (32.8%), and 86 (67.2%) were without crossing vessels. The demographic profile of patients between the 2 groups was comparable. On histopathological examination, moderate-to-severe chronic inflammation was seen in 23.8% and 44.2% (P > .05) in group 1 and group 2, respectively; fibrosis and muscular hypertrophy were higher in group 2 but statistically insignificant (P > .05), and muscle disarray was higher in group 1 but statistically insignificant (P > .05). Synaptophysin was positive in 4.8% and 4.7% in group 1 and group 2, respectively.

Conclusion:

The differences in histopathological examination between the 2 groups were not statistically significant. However, in patients with crossing vessels, there was a higher degree of inflammation, which may lead to early pelvi ureteric junction obstruction.

Keywords: Pelvi ureteric junction obstruction, histopathology, laparoscopic pyeloplasty, crossing vessel


Main Points

  • To assess whether crossing vessel is a cause or associated finding of pelvi ureteric junction obstruction, a histopathological examination of pelvi ureteric junction segment was done in patients with and without crossing vessel. Histopathological examination findings of pelvi ureteric junction segment include inflammation, fibrosis, muscle hypertrophy, muscle disarray, and synaptophysin.

  • On histopathological examination, moderate-to-severe chronic inflammation was higher in patients with crossing vessels and fibrosis and muscular hypertrophy were higher in patients without crossing vessels, but these differences were statistically insignificant.

  • Similarly, muscle disarray was statistically insignificant in patients with crossing vessels. Synaptophysin was positive in both groups.

  • Since histopathological examination findings were statistically insignificant in the patients with and without crossing vessels, it can be concluded that crossing vessel is not a cause of pelvi ureteric junction obstruction rather it is an associated finding.

  • Further studies using electron microscopy along with histopathology will be required to see the degree of different components responsible for pelvi ureteric junction obstruction. This may help in deciding whether pyeloplasty should be done or go for transposition of crossing vessels only without pyeloplasty.

Introduction

Pelvic ureteric junction obstruction (PUJO) is more common in children. It is twice as prevalent in males as it is in females, and it is twice as common on the left side as it is on the right.1 Its estimated global incidence is 1 in 1500.1 The most prevalent cause is assumed to be an intrinsic abnormality of muscle development or insufficient nerves in the obstructed PUJ segment.2 Other causes are (i) obstruction from extrinsic compression such as crossing vessel (CV), tumor compression, fibrous cord, enlarged lymph node, etc.; (ii) intramural pathology (fibrosis of PUJ segment secondary to previous surgery, stones, or tumor); (iii) intraluminal pathology (stones, polyp, mucosal folds, etc.). The role of renal CV in patients with PUJO has been the subject of debate.3-5 Although the real frequency of CV in the normal unobstructed PUJ population is unknown, studies have found that it ranges from 39% to 65%.6,7

Crossing vessel is not the primary cause of PUJO rather it is already obstructed due to intrinsic defect and it only causes partial obstruction leading to redundant pelvis kinks and falls upon increasing the vessel hydronephrosis.8 Some authors assumed that this vessel was the sole source of the obstruction, and its transposition only relieved the obstruction.9

Despite this link, the definitive causal relationship between CV and PUJO, if there is one, is unknown. The purpose of this study was to evaluate histopathological changes in PUJ segment in patients of PUJO with or without CV and whether the CV is the cause of obstruction or an associated finding.

Material and Methods

This is a prospective observational study done from January 2016 to June 2020. Patients with hydronephrosis on ultrasound had their PUJO confirmed by a diethylenetriamine pentaacetate (DTPA) scan. Patients having obstructed patterns on DTPA scan were taken for the study. All underwent laparoscopic dismembered Anderson Hynes (AH) pyeloplasty. The presence of CV was noted during surgery. After surgery, the PUJ segment was sent for histopathological examination (HPE). Patients were divided into 2 groups: group 1, PUJO with CV, and group 2, PUJO without CV. A total of 42 patients were included in group 1 and 86 patients in group 2. Data include demographic profile, laterality, presence of CV, and HE of PUJ segment including inflammation, fibrosis, muscle hypertrophy, muscle disarray, and synaptophysin.

The data were collected on a predesigned schedule and subsequently entered in Microsoft Excel®. The proportions were presented as percentages and continuous data were presented as mean ± SD. Unpaired Student t-test was used for comparing differences between continuous normally distributed data from 2 samples. The proportions were analyzed using chi-squared tests. A P-value of less than .05 was considered significant.

Prior to the recruitment of the study’s participants, written informed consent was obtained. Patients, who refused to participate in the trial, as well as those with secondary PUJO and recurrent PUJO, were excluded. Prior to the start of subject recruiting, institutional ethics and review board approval were obtained from Dr. R. M. L. Institute of Medical Sciences, Lucknow, India (IEC No: 40/17).

Surgical Assessment

All of the patients who had PUJO were treated with laparoscopic trans-peritoneal AH pyeloplasty. The pre-operative finding of CV was noted. Crossing vessels consist of an artery and/or a vein. The artery originated from aorta and vein drain to inferior vena cava. It is usually present in relation to inferior pole of the kidney. Crossing vessel was transposed posteriorly. The redundant pelvis, PUJ, and a narrow segment of the ureter below the PUJ were removed and preserved in a 10% formalin solution. This specimen was sent for HPE.

Histopathological Examination

Pelvic ureteric junction segment was assessed for inflammation, fibrosis, muscle hypertrophy, pattern of smooth muscle, and synaptophysin. All PUJ segments were fixed in 10% (wt/vol) phosphate-buffered in formalin for 24–48 h. After doing standard histological processing and embedding in paraffin, 5-µm-thick sections were used for H&E staining. These stained sections were examined for the presence of inflammation, fibrosis, muscle hypertrophy, and muscle disarray. Immunohistochemistry was done for synaptophysin. Histopathologist was blinded to the presence or absence of CV. Urothelium was evaluated for the presence or absence of metaplasia/dysplasia. In lamina propria layer, presence of fibrosis (0 = none; mild = limited to lamina propria; moderate = involving muscularis propria; severe = replacing muscularis propria and extending into adventitial layer) and inflammation (divided into mild, moderate, and severe as above) was evaluated.10

A special stain, Masson’s trichrome, was used to differentiate between fibrosis and smooth muscle hyperplasia. It was also used for defining muscle disarray. Synaptophysin staining was done to look for ganglion cells in the wall.

Results

None of the patients required conversion to open pyeloplasty after undergoing laparoscopic Anderson Hynes (AH) pyeloplasty. The incidence of CV in individuals with PUJO was 32.8% (n = 42). The demographic findings of the patients are given in Table 1.

Table 1.

Demographic Profile

Characteristic Group 1 (with CV) n = 42 (32.8%) Group 2 (without CV) n = 86 (67.2%) P
Age (mean ± SD) (years) 29.57 ± 10.50 30.05 ± 9.94 .861
Sex (male/female) 30/12 54/32 .495
Laterality(left/right) 14/28 40/46 .326
Pre-operatvie split function (mean ± SD) 29.69 ± 6.70 31.28 ± 6.29 .191
Antero-posterior pelvic diameter (cm) 7.14 ± 1.85 6.9 ± 1.95 .507

CV, crossing vessel.

There are no statistically significant differences in the HPE findings including inflammation, fibrosis, muscle hypertrophy, muscular disarray, and synaptophysin between these two groups. The HPE findings were not observed to be affected by age. The HPE findings are given in Table 2. Histopathological features are shown in Figures 1 and 2.

Table 2.

Findings of Histopathological Examination (HPE)

Characteristics Grade Group 1 (with CV) Group 2 (without CV) 95% CI P
n % n %
Inflammation M 16 76.2 24 55.8 −0.73,0.277 .114
M–S 5 23.8 19 44.2 −0.233,0.03
Fibrosis M 6 28.6 10 23.3 −0.099,0.152 .645
M–S 15 71.4 33 76.7 −0.204,0.151
Synaptophysin Positive 1 4.8 2 4.7 −0.055,0.057 1.000
Negative 20 95.2 41 95.3 −0.185,0.184
Muscle hypertrophy M 11 52.4 30 69.8 −0.254,0.08 .173
M–S 10 47.6 13 30.2 −0.062,0.236
Muscle disarray 5 23.8 3 7.0 −0.021,0.19 .102

CV, crossing vessel.

Figure 1.

Figure 1.

Fibrosis grade 2 of PUJ segment in group 1. PUJ, pelvi ureteric junction.

Figure 2.

Figure 2.

Fibrosis grade 1, mild muscle hypertrophy, absent muscle disarray of PUJ segment in group 2. PUJ, pelvi ureteric junction.

Discussion

The pathophysiology of PUJO is unknown. The decrease in distensability at the obstructed segments might be explained by a change in muscle configuration, atrophy/drop in myocytes, decrease in Cajal interstitial cells, reduction of nerve terminals, and increased collagen deposition between muscle bundles. These may contribute to the absence of the ureteropelvic muscular contractions of PUJ segment.2,11-13

On the other hand, few researchers opine that an intrinsic abnormality in muscle cells is the cause of obstruction and that morphological changes are secondary.14 The involvement of CV in the pathophysiology and histological alterations of the PUJ segment in PUJO patients is unknown. If ureter compression and obstruction caused by CV were the primary cause of PUJO, the HPE of this segment in those with and without CV should differ. Incidence of CV in literature ranges from 19.8% to 63%.2,15,16 In the present study, CV was found in 32.8% (n = 42).

Researchers like Cancian et al10 Dogan et al16 and Ellerkamp et al17 also found similar results. Dogan et al16 compared patients of PUJO without CV (n = 57), with CV (n = 17), and normal PUJ (n = 12). All cases were compared for number of interstitial cells muscle layer, number of neurons at the level of lamina propria, and presence or absence of fibrosis/inflammation. They did not find statistically significant differences. Similarly, Ellerkamp et al17 and Cancian et al10 graded fibrosis, muscle hypertrophy, and inflammation and demonstrated no differences between these two groups.

Murakumo et al2 examined histopathologically along with electron microscopy of PUJ segment of healthy (n = 7), with CV (n = 4), and without CV (n = 7). The study showed decreased nerve fibers, atrophy of muscle fibers, and increased collage deposits in patients without CV. However, there was no discernible change in the presence of synaptophysin in patients with and without CV. This could be related to the use of electron microscopy to examine nerve tissue and the small number of participants in the study.2

Contrary to present study, Lee Richstone et al15 studied 65 patients with CV and 30 patients without CV and found significant difference in histopathological changes of chronic inflammation, fibrosis, muscle hypertrophy, and muscle atrophy.15 Since this was a retrospective study based on simple H&E stained PUJ segment for chronic inflammation, fibrosis, muscle hypertrophy, and muscular atrophy, it could be difficult to identify neurological or molecular pathogenic characteristics. In the present study, a special stain, Masson’s trichrome was used to differentiate fibrosis from muscle hypertrophy. They also did not consider the grades of inflammation, fibrosis, and muscle hypertrophy rather noted the presence or absence of these. Presence of synaptophysin was detected by immune-histochemistry in the present study.

On the other hand, just transposing of CV (using Hellstrom procedure) alleviates the obstruction.18,19 This procedure can be done in PUJO with visible peristalsis in PUJ segment, apparently healthy ureter and after vascular displacement, diuretic-response with emptying of the dilated pelvis to confirm blockage release and rule out intrinsic-PUJ abnormalities.20

The presence of CV causes increased inflammation in the PUJ segment. This inflammation causes adhesion to nearby structures, causing obstruction.10 The degree or proportion of different components at PUJ was not studied. It is unknown at what percent these components cause significant blockage at the PUJ. There is dearth of studies based on HPE of PUJ segment in PUJO. The strength of our study is that we studied a larger number of patients along with studying for all components of tissue elements leading to fibrosis and obstruction. The limitation of the present study is that we did not see the degree of these components at what proportion they lead to significant obstruction at PUJ segment.

Histopathological examination of PUJ was same in both groups. It is difficult to conclude that CV is a cause or associated structure depending on the findings of the present study. Therefore, further study based on not only histopathology but also including electron microscopy should be considered. Additionally, since peristalsis is triggered and controlled by Cajal cells and the level of Caveolin-1 should be taken into account in the further studies, this may help in deciding whether we do pyeloplasty or go for transposition of CV only without pyeloplasty.

In conclusion, the differences in HPE between the two groups were not statistically significant. However, in patients with CV, there was a higher degree of inflammation, which may lead to early PUJ obstruction.

Footnotes

Ethics Committee Approval: Ethical committee approval was received from the Ethics Committee of Dr. R. M. L. Institute of Medical Sciences, Lucknow, India (IEC No: 40/17).

Informed Consent: Written informed consent was obtained from all participants who participated in this study.

Peer-review: Externally peer-reviewed.

Author Contributions: Concept – S.K.S., G.G.; Design – S.K.S., A.S., K.K.Y., N.H., A.S., C.K.M.; Supervision – S.K.S.; Materials – N.H., A.S.; Data Collection and/or Processing – G.G., C.K.M.; Analysis and/or Interpretation – A.S., K.K.Y., N.H., A.S.; Literature Review – A.S., G.G., C.K.M.; Writing Manuscript – S.K.S., K.K.Y.; Critical Review – S.K.S., K.K.Y.

Declaration of Interests: The authors declare that they have no conflict of interest.

Funding: The authors declared that this study has received no financial support.

References

  • 1. Grasso M, Caruso RP, Phillips CK. UPJ obstruction in the adult population: are crossing vessels significant? Rev Urol. 2001;3(1):42 51. [PMC free article] [PubMed] [Google Scholar]
  • 2. Murakumo M, Nonomura K, Yamashita T, Ushiki T, Abe K, Koyanagi T. Structural changes of collagen components and diminution of nerves in congenital ureteropelvic junction obstruction. J Urol. 1997;157(5):1963 1968. 10.1016/S0022-5347(01)64910-3) [DOI] [PubMed] [Google Scholar]
  • 3. Sampaio FJ. The dilemma of the crossing vessel at the ureteropelvic junction: precise anatomic study. J Endourol. 1996;10(5):411 415. 10.1089/end.1996.10.411) [DOI] [PubMed] [Google Scholar]
  • 4. Sampaio FJ. Vascular anatomy at the ureteropelvic junction. Urol Clin North Am. 1998;25(2):251 258. 10.1016/s0094-0143(05)70012-4) [DOI] [PubMed] [Google Scholar]
  • 5. Zeltser IS, Liu JB, Bagley DH. The incidence of crossing vessels in patients with normal ureteropelvic junction examined with endoluminal ultrasound. J Urol. 2004;172(6 Pt 1):2304 2307. 10.1097/01.ju.0000145532.48711.f6) [DOI] [PubMed] [Google Scholar]
  • 6. Sampaio FJB. Ureteropelvic junction anatomy. Atlas Urol Clin. 2003;11(2):129 140. 10.1016/S1063-5777(03)00042-2) [DOI] [Google Scholar]
  • 7. Van Cangh PJ, Wilmart JF, Opsomer RJ, Abi-Aad A, Wese FX, Lorge F. Long term results and late recurrence after endopyelotomy:a critical analysis of prognostic factors. J Urol. 1994;151(4):934-937. 10.1016/s0022-5347(17)35126-1) [DOI] [PubMed] [Google Scholar]
  • 8. De Siati M, Silvestre P, Scieri F, Breda G. Congenital ureteropelvic junction obstruction:definition and therapy. Arch Ital Urol Androl. 2005;77(1):1 4. [PubMed] [Google Scholar]
  • 9. Sakoda A, Cherian A, Mushtaq I. Laparoscopic transposition of lower pole crossing vessels (‘vascular hitch’) in pure extrinsic pelviureteric junction (PUJ) obstruction in children. BJU Int. 2011;108(8):1364 1368. 10.1111/j.1464-410X.2011.10657.x) [DOI] [PubMed] [Google Scholar]
  • 10. Cancian M, Pareek G, Caldamone A, Aguiar L, Wang H, Amin A. Histopathology in ureteropelvic junction obstruction With and Without crossing vessels. Urology. 2017;107:209 213. 10.1016/j.urology.2017.05.013) [DOI] [PubMed] [Google Scholar]
  • 11. Solari V, Piotrowska AP, Puri P. Altered expression of interstitial cells of Cajal in congenital ureteropelvic junction obstruction. J Urol. 2003;170(6 Pt 1):2420 2422. 10.1097/01.ju.0000097401.03293.f0) [DOI] [PubMed] [Google Scholar]
  • 12. Hanna MK, Jeffs RD, Sturgess JM, Barkin M. Ureteral structure and ultrastructure. Part II. Congenital ureteropelvic junction obstruction and primary obstructive megaureter. J Urol. 1976;116(6):725 730. 10.1016/s0022-5347(17)58987-9) [DOI] [PubMed] [Google Scholar]
  • 13. Seremetis GM, Maizels M. TGF-beta mRNA expression in the renal pelvis after experimental and clinical ureteropelvic junction obstruction. J Urol. 1996;156(1):261 266. 10.1016/S0022-5347(01)66013-0) [DOI] [PubMed] [Google Scholar]
  • 14. Gosling JA, Dixon JS. Functional obstruction of the ureter and renal pelvis. A histological and electron microscopic study. Br J Urol. 1978;50(3):145 152. 10.1111/j.1464-410x.1978.tb02790.x) [DOI] [PubMed] [Google Scholar]
  • 15. Richstone L, Seideman CA, Reggio E.et al. Pathologic findings in patients with ureteropelvic junction obstruction and crossing vessels. Urology. 2009;73(4):716 9; discussion 719. 10.1016/j.urology.2008.10.069) [DOI] [PubMed] [Google Scholar]
  • 16. Doğan HT, Canda AE, Gök B.et al. Is there a difference in the number of interstitial cells, neurons, presence of fibrosis and inflammation in ureteropelvic junction tissues of patients with ureteropelvic junction obstruction with and without crossing vessels? Turk J Urol. 2019;45(4):302 306. 10.5152/tud.2018.08784) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Ellerkamp V, Kurth RR, Schmid E, Zundel S, Warmann SW, Fuchs J. Differences between intrinsic and extrinsic ureteropelvic junction obstruction related to crossing vessels: histology and functional analyses. World J Urol. 2016;34(4):577 583. 10.1007/s00345-015-1645-x) [DOI] [PubMed] [Google Scholar]
  • 18. Godbole P, Mushtaq I, Wilcox DT, Duffy PG. Laparoscopic transposition of lower pole vessels--the 'vascular hitch': an alternative to dismembered pyeloplasty for pelvi-ureteric junction obstruction in children. J Pediatr Urol. 2006;2(4):285 289. 10.1016/j.jpurol.2005.11.017) [DOI] [PubMed] [Google Scholar]
  • 19. Madec FX, Faraj S, Villemagne T, Fourcade L, Lardy H, Leclair MD. Laparoscopic transposition of lower-pole crossing vessels: long-term follow-up of 33 patients at puberty. J Pediatr Urol. 2016;12(4):226.e1 226.e6. 10.1016/j.jpurol.2016.03.016) [DOI] [PubMed] [Google Scholar]
  • 20. Esposito C, Bleve C, Escolino M.et al. Laparoscopic transposition of lower pole crossing vessels (vascular hitch) in children with pelviureteric junction obstruction. Transl Pediatr. 2016;5(4):256 261. 10.21037/tp.2016.09.08) [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Turkish Journal of Urology are provided here courtesy of Turkish Association of Urology

RESOURCES